Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers

Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers

US Patent 11266639 · Granted Mar 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Piperazine derivatives, pharmaceutical compositions and methods of use thereof2024
Piperazine derivatives, pharmaceutical compositions and methods of use thereof2024
Use of hexokinase 2/mitochondria-detaching compounds for activating immune respo2024
Use of hexokinase 2/mitochondria-detaching compounds for activating immune respo2024
Use of hexokinase 2/mitochondria-detaching compounds for activating immune respo2024
Methods for preparation of jasmonate compounds2024
Use of hexokinase 2/mitochondria-detaching compounds for activating immune respo2021
Use of hexokinase 2/mitochondria-detaching compounds for activating immune respo2021
Use of hexokinase 2/mitochondria-detaching compounds for activating immune respo2021
Piperazine derivatives, pharmaceutical compositions and methods of use thereof2021
Piperazine derivatives, pharmaceutical compositions and methods of use thereof2021
Use of hexokinase 2/mitochondria-detaching compounds for activating immune respo2020